List of articles with "AbbVie"

New HCV Treatment Approved

2026-08-07 03:07:27

None AbbVie Gracaprevir Velpatasvir

Epcoritamab Approval

2026-08-05 01:20:30

United States Epcoritamab AbbVie North Chicago Relapsed Follicular Lymphoma

BOTOX® Expansion

2026-08-04 12:14:58

United States Irvine AbbVie Allergan Aesthetics BOTOX Cosmetic

AbbVie Q2 Report

2026-07-31 11:51:15

United States AbbVie North Chicago Skyrizi RINVOQ

RINVOQ® Approval in EU

2026-07-29 07:07:34

None AbbVie Alopecia Areata RINVOQ

AbbVie Approval for Vitiligo

2026-07-29 07:05:30

None AbbVie RINVOQ Vitiligo

Resankizumab FDA Approval

2026-07-22 04:31:43

United States AbbVie North Chicago Pediatrics Resankizumab

Risankizumab Approval

2026-07-22 04:31:27

United States Psoriasis AbbVie North Chicago Risankizumab

AbbVie EHA 2026 Insights

2026-07-07 04:46:07

United States AbbVie North Chicago EHA 2026 hematologic cancer

TEPKINLY® Approved

2026-07-06 17:48:36

None Epcoritamab AbbVie TEPKINLY

AbbVie TEPKINLY® Approval

2026-07-06 17:48:19

None Epcoritamab AbbVie TEPKINLY

AbbVie Art Project

2026-07-06 04:19:59

Japan Tokyo AbbVie Perspectives Art Project

Phase 3 Trial Results

2026-06-29 21:00:16

USA Epcoritamab AbbVie North Chicago DLBCL

Epcoritamab Phase 3 Results

2026-06-29 20:28:55

United States Epcoritamab AbbVie North Chicago DLBCL

AbbVie Advances Alopecia Treatment

2026-06-29 07:16:13

USA AbbVie North Chicago Alopecia Areata Upadacitinib

AbbVie's New Treatment

2026-06-29 07:15:42

USA AbbVie North Chicago RINVOQ Upadacitinib

Upadacitinib for Vitiligo

2026-06-29 07:05:07

USA AbbVie North Chicago Upadacitinib Vitiligo

Upadacitinib and Vitiligo

2026-06-29 07:04:49

USA AbbVie North Chicago Upadacitinib Vitiligo

AbbVie Atogepant Approval

2026-06-29 05:19:30

None AbbVie North Chicago Migraine Atogepant

SKYRIZI Approved for Kids

2026-06-26 20:58:52

United States AbbVie North Chicago Skyrizi Risankizumab

Must-See Press Releases

2026-06-26 10:09:29

USA New York Taco Bell AbbVie Mountain Dew

AbbVie Venetoclax EC Approval

2026-06-25 02:54:22

United States AbbVie North Chicago CLL venetoclax

AbbVie's Etentamig Breakthrough

2026-06-24 05:20:01

Japan Tokyo AbbVie AL Amyloidosis Etentamig

Aesthetic AI Citation Leaders

2026-06-23 18:53:20

USA Boca Raton Aesthetic Medicine AbbVie Galderma

MAVIRET® Receives EU Approval

2026-06-23 09:20:41

None AbbVie Hepatitis C MAVIRET®

AbbVie SKYRIZI Approval

2026-06-23 07:16:07

None Psoriasis AbbVie Skyrizi

AbbVie SKYRIZI® Approval

2026-06-23 07:13:41

None Psoriasis AbbVie Skyrizi

AbbVie Acquires Apogee

2026-06-22 11:17:06

USA Apogee AbbVie North Chicago Immunology

AbbVie Acquires Apogee

2026-06-22 11:11:55

USA AbbVie North Chicago Immunology Apogee Therapeutics

AbbVie Announces Dividend

2026-06-18 20:24:34

USA Dividend AbbVie North Chicago SP Dividend Aristocrats

AbbVie Innovation

2026-06-15 02:27:52

Japan Innovation Tokyo AbbVie BioLabs

AbbVie Venetoclax Update

2026-06-12 07:22:59

USA AbbVie North Chicago CLL venetoclax

AbbVie Presents CLL Study

2026-06-12 07:21:26

USA AbbVie North Chicago CLL VENCLYXTO

Risankizumab Approval

2026-06-12 05:20:08

Japan Tokyo Crohn's Disease AbbVie Risankizumab

AbbVie Upadacitinib

2026-06-12 05:19:48

Japan Tokyo AbbVie Upadacitinib Takayasu Arteritis

AbbVie ASCO 2026 Reveal

2026-06-10 05:12:36

United States oncology AbbVie North Chicago ASCO 2026

AbbVie Blood Cancer Insights

2026-06-08 12:37:00

USA Blood Cancer Epcoritamab AbbVie North Chicago

AbbVie at EHA 2026

2026-06-08 12:18:14

USA Blood Cancer AbbVie North Chicago EHA 2026

AbbVie IBD Updates

2026-06-03 02:30:40

United States AbbVie North Chicago IBD Risankizumab

AbbVie at Goldman Sachs

2026-06-02 12:49:47

USA Goldman Sachs Healthcare Conference AbbVie North Chicago

AQUIPTA® Approval

2026-06-02 08:10:38

None AbbVie Migraine AQUIPTA

VENCLYXTO® Label Expanded

2026-05-29 12:14:35

USA AbbVie North Chicago CLL VENCLYXTO

AbbVie's VENCLYXTO Update

2026-05-29 12:13:21

USA AbbVie North Chicago CLL Treatment VENCLYXTO

FDA Approves DECNUPAZ

2026-05-27 22:20:20

USA AbbVie North Chicago BPDCN DECNUPAZ

AbbVie Makes FDA Move

2026-05-25 02:19:53

United States AbbVie North Chicago Alopecia Areata Upadacitinib

MAVIRET® Makes Headway

2026-05-22 12:13:01

USA AbbVie North Chicago Hepatitis C MAVIRET

AbbVie Crohn's Treatment

2026-05-22 02:20:27

United States Crohn's Disease AbbVie North Chicago Risankizumab

AbbVie at ASCO 2026

2026-05-21 22:59:37

United States Chicago oncology AbbVie ASCO 2026

AbbVie at Healthcare Conference

2026-05-06 12:22:57

United States Healthcare Conference pharmaceuticals AbbVie North Chicago

AbbVie IBD Treatment Data

2026-05-05 12:12:48

None Chicago AbbVie Skyrizi RINVOQ